Oxholm P and Winther K |
Thrombocyte involvement in immune inflammatory reactions. |
1986 |
Allergy |
pmid:3515999
|
Kurosawa M et al. |
Increased levels of blood platelet-activating factor in bronchial asthmatic patients with active symptoms. |
1994 |
Allergy |
pmid:8198242
|
Mishra RK et al. |
Differential dependence of eosinophil chemotactic responses on phosphoinositide 3-kinase (PI3K). |
2005 |
Allergy |
pmid:16076309
|
Howarth PH |
Mediators of nasal blockage in allergic rhinitis. |
1997 |
Allergy |
pmid:9353555
|
Bachert C |
Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis. |
2001 |
Allergy |
pmid:11243500
|
Oxholm P et al. |
Lack of evidence for human lymphokines with thrombocyte aggregating activity. An in vitro study. |
1984 |
Allergy |
pmid:6528957
|
Dunoyer-Geindre S et al. |
PAF acether release on antigenic challenge. A method for the investigation of drug allergic reactions. |
1992 |
Allergy |
pmid:1590567
|
Mullol J et al. |
Rupatadine in allergic rhinitis and chronic urticaria. |
2008 |
Allergy |
pmid:18339040
|
Juhlin L |
A comparison of the pharmacodynamics of H1-receptor antagonists as assessed by the induced wheal-and-flare model. |
1995 |
Allergy |
pmid:7645678
|
Meltzer EO |
The use of anti-H1 drugs in mild asthma. |
1995 |
Allergy |
pmid:7645681
|
Pipkorn U et al. |
Effect of platelet activating factor on the human nasal mucosa. |
1984 |
Allergy |
pmid:6703263
|
Di Leo E et al. |
Treatment of acquired cold urticaria with rupatadine. |
2009 |
Allergy |
pmid:19392988
|
Soyombo O et al. |
Effects of lipoxin A4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. |
1994 |
Allergy |
pmid:8037356
|
Takafuji S et al. |
Release of granule proteins from human eosinophils stimulated with mast-cell mediators. |
1998 |
Allergy |
pmid:9821474
|
Leggieri E et al. |
Study of the effects of paf-acether on human nasal airways. |
1991 |
Allergy |
pmid:1720286
|
Mukai K et al. |
New insights into the roles for basophils in acute and chronic allergy. |
2009 |
Allergol Int |
pmid:19153532
|
Negro Alvarez JM et al. |
Platelet-activating factor antagonists. |
1997 Sep-Oct |
Allergol Immunopathol (Madr) |
pmid:9395010
|
MonteseirÃn J et al. |
Formation of lipids, peptides and cytokines. |
1996 Sep-Oct |
Allergol Immunopathol (Madr) |
pmid:8985477
|
Miadonna A et al. |
Induction and control of allergic inflammation in human respiratory airways. |
1993 May-Jun |
Allergol Immunopathol (Madr) |
pmid:7689291
|
Rihoux JP |
[Allergic reaction and vascular permeability]. |
1990 |
Allerg Immunol (Paris) |
pmid:2288644
|
Beauvais F and Benveniste J |
[IgE and anaphylaxis mediators]. |
1987 |
Allerg Immunol (Paris) |
pmid:2968802
|
Mencia-Huerta JM et al. |
[Effect of long-term administration of platelet activating factor on pulmonary response and morphology in the guinea pig]. |
1988 |
Allerg Immunol (Paris) |
pmid:3245884
|
Ligumsky M et al. |
The role of platelet activating factor [correction of actor] in acute gastric injury and its protection by sucralfate. |
1990 |
Aliment. Pharmacol. Ther. |
pmid:2129638
|
Greenberg SS et al. |
Ethanol suppresses endotoxin but not platelet activating factor-induced hypotension and nitric oxide. |
1996 |
Alcohol. Clin. Exp. Res. |
pmid:8904980
|
Saleh AA et al. |
Effect of alcohol on platelet-activating factor acetylhydrolase activity in pregnant and nonpregnant mice. |
1994 |
Alcohol. Clin. Exp. Res. |
pmid:7978079
|
Baker RC et al. |
Effects of ethanol on human platelets stimulated with platelet-activating factor, a biologically active ether phospholipid. |
1989 |
Alcohol. Clin. Exp. Res. |
pmid:2557776
|
Lands WE |
Cellular signals in alcohol-induced liver injury: a review. |
1995 |
Alcohol. Clin. Exp. Res. |
pmid:7485841
|
Kelesidis T et al. |
The Role of Platelet-Activating Factor in Chronic Inflammation, Immune Activation, and Comorbidities Associated with HIV Infection. |
|
AIDS Rev |
pmid:26616844
|
Chini M et al. |
Effects of HAART on platelet-activating factor metabolism in naive HIV-infected patients I: study of the tenofovir-DF/emtricitabine/efavirenz HAART regimen. |
2012 |
AIDS Res. Hum. Retroviruses |
pmid:22050695
|
Lima RG et al. |
Interaction of macrophages with apoptotic cells enhances HIV Type 1 replication through PGE2, PAF, and vitronectin receptor. |
2006 |
AIDS Res. Hum. Retroviruses |
pmid:16910832
|
Tsoupras AB et al. |
Anti-platelet-activating factor effects of highly active antiretroviral therapy (HAART): a new insight in the drug therapy of HIV infection? |
2008 |
AIDS Res. Hum. Retroviruses |
pmid:18620493
|
Rihoux JP |
The inhibiting effect of cetirizine 2 HC1 on eosinophil migration and its link to H1 blockade. |
1991 |
Agents Actions Suppl. |
pmid:1675836
|
König W et al. |
On the biological role of lipid chemotactic factors. |
1983 |
Agents Actions Suppl. |
pmid:6404145
|
Kurosawa M |
Effect of platelet activating factor on histamine release from rat mast cells. |
1987 |
Agents Actions Suppl. |
pmid:2445185
|
Goldie RG et al. |
PAF receptors in guinea-pig and human lung. |
1990 |
Agents Actions Suppl. |
pmid:1964365
|
Page CP et al. |
Drugs affecting pulmonary responses to platelet activating factor as novel anti-asthma drugs. |
1988 |
Agents Actions Suppl. |
pmid:3051932
|
Muirhead EE |
Vasodepressor lipid of the renomedullary interstitial cells of the renal papilla is a prohormone activated by the liver. |
1987 |
Agents Actions Suppl. |
pmid:3324720
|
Page CP and Robertson DN |
Properties of PAF relevant to asthma. |
1987 |
Agents Actions Suppl. |
pmid:3314416
|
Morley J |
PAF and airway hyperreactivity; prospects for novel prophylactic anti-asthma drugs. |
1987 |
Agents Actions Suppl. |
pmid:3314417
|
Braquet P et al. |
The role of PAF-acether in anaphylaxis demonstrated with the use of the antagonist BN 52021. |
1987 |
Agents Actions Suppl. |
pmid:3314418
|
Vargaftig BB |
Phospholipids, particularly platelet-activating factor (PAF-acether), in experimental bronchoconstriction. |
1983 |
Agents Actions Suppl. |
pmid:6575594
|
Morley J et al. |
Pharmacological evaluation of prophylactic anti-asthma drugs by reference to the pathological sequelae of exposure to allergen or platelet activating factor. |
1988 |
Agents Actions Suppl. |
pmid:3262989
|
Subissi A and Criscuoli M |
Effects of LG 30435 on different platelet activating factor-induced responses. |
1988 |
Agents Actions Suppl. |
pmid:3262990
|
Heuer H and Casals-Stenzel J |
Effect of the PAF-antagonist WEB 2086 on anaphylactic lung reaction: comparison of inhalative and intravenous challenge. |
1988 |
Agents Actions Suppl. |
pmid:3262991
|
Hartung HP et al. |
Stimulation of the oxidative burst in macrophages with platelet activating factor (PAF-acether). |
1982 |
Agents Actions Suppl. |
pmid:6960648
|
Szczeklik A et al. |
Bleeding time and PAF-acether-induced platelet aggregation in atopy. |
1987 |
Agents Actions Suppl. |
pmid:3478996
|
Schmitz-Schumann M et al. |
Evidence of PAF release and platelet activation in analgesics-asthma-syndrome. |
1987 |
Agents Actions Suppl. |
pmid:3478999
|
Guinot P et al. |
Effects of BN 52063 on PAF-acether induced weal and flare in man. |
1987 |
Agents Actions Suppl. |
pmid:3479000
|
Lang M et al. |
Effects of the PAF-antagonist CV-3988 on PAF-induced changes in mucus secretion and in respiratory and circulatory variables in ferrets. |
1987 |
Agents Actions Suppl. |
pmid:3479001
|
Codde JP et al. |
Effects of altered prostanoid and lyso-PAF synthesis by marine oil diets on blood pressure of salt loaded spontaneously hypertensive rats. |
1987 |
Agents Actions Suppl. |
pmid:3481207
|